FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Noriko Gotoh, Kang Wang et al.|Journal of Clinical Investigation|2023Cited by 29
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myelomaMitsuhito Hirano, Arinobu Tojo|Journal of Experimental & Clinical Cancer Research|2021Cited by 24
Small-molecule HDAC and Akt Inhibitors Suppress Tumor Growth and Enhance Immunotherapy in Multiple MyelomaMitsuhito Hirano, Arinobu Tojo|Research Square|2020Cited by 0